DCPH - Deciphera Pharmaceuticals LLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $31.64. This is a potential upside of $6.05 (23.64%) from yesterday's end of day stock price of $25.59.

Deciphera Pharmaceuticals LLC's activity chart (see below) currently has 141 price targets and 105 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.21% with an average time for these price targets to be met of 199.25 days.

Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 09-May-2024. First documented stock forecast 22-Oct-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$23

$-2.59 (-10.12%)

$23

1 years 5 months 14 days ago
(09-May-2024)

6/9 (66.67%)

$-2.36 (-9.31%)

90

Sell

$26

$0.41 (1.60%)

$9

1 years 5 months 24 days ago
(29-Apr-2024)

3/10 (30%)

$0.73 (2.89%)

235

Hold

$22

1 years 5 months 24 days ago
(29-Apr-2024)

2/3 (66.67%)

$2.24 (11.34%)

67

Hold

$23

1 years 5 months 25 days ago
(28-Apr-2024)

4/6 (66.67%)

$8.58 (59.50%)

352

Hold

$16

$-9.59 (-37.48%)

1 years 5 months 25 days ago
(28-Apr-2024)

0/3 (0%)

$-9.28 (-36.71%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DCPH (Deciphera Pharmaceuticals LLC) average time for price targets to be met?

On average it took 199.25 days on average for the stock forecasts to be realized with a an average price target met ratio 65.21

Which analyst has the current highest performing score on DCPH (Deciphera Pharmaceuticals LLC) with a proven track record?

CHRISTOPHER MARAI

Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals LLC)?

Christopher Marai has 8 price targets and 6 ratings on DCPH

Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals LLC)?

Konstantinos Aprilakis with highest potential upside - $49.41

Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals LLC)?

Robyn Karnauskas with lowest potential downside - -$15.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?